3rd International ADHD Congress – ISAD 2022

Held under the theme "Neurodevelopmental Disorders: A View to the Future," the congress explored ADHD within the broader context of neurodevelopmental disorders. The scientific programme addressed current developments in diagnosis and treatment, medical comorbidities, recent international consensus statements, and the impact of the COVID-19 pandemic on people with ADHD.

Additional sessions covered advances in basic science, emerging pharmacological and non-pharmacological treatments, and the future of interdisciplinary collaboration in ADHD research and clinical practice.

Alongside keynote lectures and scientific symposia, the congress featured practical workshops, discussions on professional education in ADHD, and interactive sessions encouraging dialogue between clinicians, researchers and educators from around the world. The meeting reflected the Federation's commitment to international collaboration and the exchange of evidence-based knowledge across disciplines.

The congress was organised through the collaboration of the World Federation of ADHD, the Israeli Society of ADHD (ISAD), the European Network Adult ADHD (ENAA) and APSARD (The American Professional Society of ADHD and Related Disorders). This partnership brought together expertise from multiple regions and highlighted the importance of international cooperation in advancing ADHD research, education and clinical care.